Abstract
p53 in cytoplasm displays an intrinsic 3′→5′ exonuclease activity. To understand the significance of p53 exonuclease activity in cytoplasm, cytoplasmic extracts of various cell lines were examined for exonuclease activity with different single-stranded RNA (ssRNA) substrates. Using an in vitro RNA degradation assay, we observed in cytoplasmic extracts of LCC2 cells, expressing high levels of endogenous wtp53, an efficient 3′→5′ exonuclease activity with RNA substrates, removing the 3′-terminal nucleotides. Interestingly, RNA containing AU-rich sequences (ARE) is the permissive substrate for exonucleolytic degradation. Evidence that exonuclease function with RNA detected in cytoplasmic extracts is attributed to the p53 is supported by several facts: (1) this activity closely parallels with status and levels of endogenous cytoplasmic p53; (2) the endogenous exonuclease exerts identical RNA substrate specificity and excision profile characteristic for purified baculovirus—or bacterially-expressed wtp53s; (3) the exonuclease activity with ARE RNA is competed out by the presence of ss or double-stranded DNA substrate utilized by p53 protein in cytoplasm; (4) immunoprecipitation by specific anti-p53 antibodies markedly reduced the exonuclease activity with both RNA and DNA substrates; and (5) transfection of the wtp53, but not exonuclease-deficient mutant p53-R175H, into p53-null H1299 or HCT116 cells induced high levels of exonuclease activity with ARE RNA substrate in cytoplasm with characteristic excision profile. The efficient ARE RNA degradation correlates with the efficient binding of p53 to ARE RNA in cytoplasm. The possible role of p53 exonuclease activity in ARE-mRNA destabilization in cytoplasm, which may be important for expression of proteins that control cell growth and/or apoptosis is discussed.
Similar content being viewed by others
References
Albrechtsen N, Dornreiter I, Grosse F, Kim E, Wiesmuller L, Deppert W (1999) Maintenance of genomic integrity by p53: complementary roles for activated p53. Oncogene 18:7708–7717
Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112–126
Lane DP (1992) Cancer: p53, guardian of the genome. Nature 358:15–16
Soussi T (1995) The p53 tumor suppressor gene: from molecular biology to clinical investigation. In: Cowell JK (ed) Molecular genetics of cancer Bios Scientific. Oxford, UK, pp 135–178
Hwang BJ, Ford JM, Hanawalt PC, Chu G (1999) Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci U S A 96:424–428
Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z, Rotter V (1999) Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett 450:197–204
Zhou J, Ahn J, Wilson SH, Prives C (2001) A role for p53 in base excision repair. EMBO J 20:914–923
Huang P (1998) Excision of mismatched nucleotides from DNA: a potential mechanism for enhancing DNA replication fidelity by the wild-type p53 protein. Oncogene 17:261–270
Marchenko ND, Zaika A, Moll UM (2000) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275:16202–16212
Fontoura BMA, Sorokina EA, David E, Carroll RB (1992) p53 is covalently linked to 5.8S rRNA. Mol Cell Biol 12:5145–5151
Marechal V, Elenbaas B, Piette J, Nicolas J, Levine AJ (1994) The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol 4:7414–7420
Miller SJ, Suthiphongchai T, Zambetti GP, Ewen ME (2000) p53 binds selectively to the 5' untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4. Mol Cell Biol 20:8420–8431
Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W (1995) Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 14:4442–4449
Lilling G, Novitsky E, Sidi Y, Bakhanashvili M (2003) p53-associated 3′→5′ exonuclease activity in nuclear and cytoplasmic compartments of cells. Oncogene 22:233–245
Bakhanashvili M, Novitsky E, Lilling G, Rahav G (2004) p53 in cytoplasm may enhance the accuracy of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Oncogene 23:6890–6899
Bakhanashvili M, Novitsky E, Rubinstein E, Levy I, Rahav G (2005) Excision of nucleoside analogs from DNA by p53 protein, a potential cellular mechanism of resistance to inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 49:1576–1579
Bakhanashvili M, Rahav G (2006) A role for tumor suppressor protein p53 in the fidelity of DNA synthesis and resistance towards nucleoside analogs. Curr Cancer Ther Rev 2:231–241
Chen C-YA, Shyu A-B (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20:465–470
Mukherjee D, Gao M, O’Connor JP, Raijmakers R, Pruijn G, Lutz CS, Wilusz J (2002) The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 21:165–174
Hirsch HH, Backenstoss V, Moroni C (1996) Impaired interleukin-3 mRNA decay in autocrine mast cell tumors after transient calcium ionophore stimulation. Growth Factors 13:99–110
Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N (1994) A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9:1925–1929
Oberosler P, Hloch P, Ramsperger U, Stahl H (1993) p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J 12:2389–2396
Yoshida Y, Izumi H, Torigoe T, Ishiguchi H, Yoshida T, Itoh H, Kohno K (2004) Binding of RNA to p53 regulates its oligomerization and DNA-binding activity. Oncogene 23:4371–4379
Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M, Aloni I (1993) Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene 8:1183–1193
Bakhanashvili M, Hizi A (1992b) The fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency viruses types 1 and 2 and of murine leukemia virus: mispair extension frequencies. Biochemistry 31:9393–9398
Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499
Mummenbrauer T, Janus F, Muller B, Wiesmuller L, Deppert W, Gross F (1996) p53 protein exhibits 3′ -to 5 exonuclease activity. Cell 85:1089–1099
Skalski V, Lin Z, Choi BY, Brown KR (2000) Substrate specificity of the p53-associated 3′→5′ exonuclease. Oncogene 19:3321–3329
Bakhanashvili M (2001a) Exonucleolytic proofreading by p53 protein. Eur J Biochem 268:2047–2054
Bakhanashvili M (2001b) p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Oncogene 20:7635–7644
Melle C, Nasheuer H (2002) Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase α-primase. Nucleic Acids Res 30:1493–1499
Lilling G, Nordenberg J, Rotter V, Goldfinger N, Peller S, Sidi Y (2002) Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells. Cancer Invest 20:509–517
Fialcowitz EJ, Brewer BY, Keenan BP, Wilson GM (2005) A hairpin-like structure within an AU-rich mRNA-destabilizing element regulates trans-factor binding selectivity and mRNA decay kinetics. J Biol Chem 280:22406–22417
Zhang T, Kruys V, Huez G, Gueydan C (2002) AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem Soc Trans 30:952–958
Peng SS, Chen C-YA, Shyu A-B (1996) Functional characterization of a non-AUUUA AU-rich element from the c-jun proto-oncogene mRNA: evidence for a novel class of AU-rich elements. Mol Cell Biol 16:1490–1499
Meek DW (1998) New developments in the multi-site phosphorylation and integration of stress signalling at p53. Int J Radiat Biol 74:729–737
Gaitonde SV, Riley JR, Qiao D, Martinez JD (2000) Conformational phenotype of p53 is linked to nuclear translocation. Oncogene 19:4042–4049
Worthington MT, Pelo JW, Sachedina MA, Applegate JL, Arseneau KO, Pizzaro TT (2002) RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein. J Biol Chem 277:48558–48564
Zubiaga AM, Belasco JG, Greenberg ME (1995) The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15:2219–2230
Stoecklin G, Gross B, Ming X, Moroni C (2003) A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. Oncogene 22:3554–3561
Acknowledgements
The authors thank Elena Novitsky for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bakhanashvili, M., Gedelovich, R., Grinberg, S. et al. Exonucleolytic degradation of RNA by p53 protein in cytoplasm. J Mol Med 86, 75–88 (2008). https://doi.org/10.1007/s00109-007-0247-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-007-0247-5